Loading...

Home
ETF
PYXS

PYXS

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Technical News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press
Privacy
Terms of Service
Service Terms of Use

Resources

Blog
Tutorial
Help Center
Affiliate Program

Markets

Market Analysis
Crypto
Featured Screeners
AI Earnings Calendar
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

QuantAI Alpha Pick
SwingMax Portfolio
Swing Trading
AI Stock Picker
Whales Auto Tracker
Daytrading Center
Patterns Detection
AI Screener
Financial AI Agent
Backtesting Playground
AI Earnings Prediction
Stock Monitor
Technical Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

PYXS News

Gas Utilities Stocks Show Strong Performance

1d agoNASDAQ.COM

NASDAQ 100 Pre-Market Activity Overview

Jun 30 2026NASDAQ.COM

Pyxis Oncology Secures $50 Million Financing to Extend Cash Runway

Jun 30 2026Newsfilter

Pyxis Oncology Q1 Earnings Miss Expectations

May 14 2026seekingalpha

Pyxis Oncology to Participate in Upcoming Investor Conferences

May 13 2026Newsfilter

Pyxis Oncology's maMICVO Shows Anti-Tumor Activity in HNSCC Model

Apr 17 2026Newsfilter

Pyxis Oncology Reports Expanded Losses and Milestones for MICVO

Mar 23 2026NASDAQ.COM

PYXIS ONCOLOGY INC ANTICIPATES FUNDING TO LAST THROUGH Q4 2026

Mar 23 2026moomoo

Pyxis Oncology Reports Q4 Earnings Miss with Revenue Decline

Mar 23 2026seekingalpha

PYXIS ONCOLOGY RELEASES BUSINESS UPDATE ALONG WITH FOURTH QUARTER AND FULL YEAR 2025 FINANCIAL RESULTS

Mar 23 2026moomoo

PYXIS ONCOLOGY Reports FY EPS of USD -1.28

Mar 23 2026moomoo

Oncolytics Biotech Advances Immunotherapy for Accelerated Approval in Oncology

Jan 12 2026Newsfilter

ALX Oncology Gains 10.17% on Positive Phase 2 Trial Data for Evorpacept

Jan 08 2026NASDAQ.COM

Experts Raise Concerns About Pyxis Oncology's Small Clinical Trial

Dec 19 2025Benzinga

Tesla's Price Target of $444? Check Out 10 Leading Analyst Predictions for Friday

Dec 19 2025Benzinga

Nasdaq Rises More Than 200 Points as US Inflation Decreases to 2.7%

Dec 18 2025Benzinga